Safeguarding High-Flow Oxygen Therapy
High-flow oxygen therapy is non-invasive respiratory support that delivers warmed, humidified, oxygen-enriched air to patients. It is typically used for spontaneously breathing patients who require oxygen at higher flow rates. Especially high flow nasal cannula (HFNC) oxygen therapy can provide respiratory support for patients with acute hypoxemic respiratory failure and may help to prevent subsequent intubation.
In preterm infants high flow O2 therapy with HFNC has similar rates of efficacy to other forms of non-invasive respiratory support for preventing treatment failure, death and chronic lung disease (CLD).
High-Flow nasal oxygen therapy is the most widely applied intervention for the treatment of hypoxemic respiratory failure due to COVID-19.
Menga LS et al. Noninvasive respiratory support for acute respiratory failure due to COVID-19 Curr Opin. Crit Care. 2022 Feb
This is O2 Therapy
O2 therapy is suitable for use as respiratory support for adults, pediatric patients, and neonates who can inhale and exhale spontaneously. In O2 therapy, a set flow of heated and humidified breathing gas with a specified oxygen concentration is supplied to the patient. This continuous oxygen flow could be applied via oxygen masks or nasal cannulas.
A growing body of evidence supports that HFNC can be used safely and effectively as an alternative to non-invasive therapies in NICU for term and pre-term infants following extubation.
Wilkinson D et al. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD006405. DOI: 10.1002/14651858.CD006405.pub3.
This is Safeguarding High-Flow Therapy
Do you want to get an overview about current publication and studies focusing on high-flow therapy? Check out our literature lists: